Detailed information for compound 224115

Basic information

Technical information
  • TDR Targets ID: 224115
  • Name: N-[3,5-bis(trifluoromethyl)phenyl]-2-chloro-4 -(1,1,2,2,2-pentafluoroethyl)pyrimidine-5-car boxamide
  • MW: 487.655 | Formula: C15H5ClF11N3O
  • H donors: 1 H acceptors: 3 LogP: 5.36 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ncc(c(n1)C(C(F)(F)F)(F)F)C(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F
  • InChi: 1S/C15H5ClF11N3O/c16-11-28-4-8(9(30-11)12(17,18)15(25,26)27)10(31)29-7-2-5(13(19,20)21)1-6(3-7)14(22,23)24/h1-4H,(H,29,31)
  • InChiKey: XYMYOQHYWDKQLT-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-[3,5-bis(trifluoromethyl)phenyl]-2-chloro-4-(1,1,2,2,2-pentafluoroethyl)-5-pyrimidinecarboxamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens v-rel avian reticuloendotheliosis viral oncogene homolog A References
Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 Starlite/ChEMBL References
Homo sapiens jun proto-oncogene Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis jun protein Get druggable targets OG5_131442 All targets in OG5_131442
Echinococcus granulosus Basic leucine zipper bZIP transcription factor Get druggable targets OG5_131442 All targets in OG5_131442
Brugia malayi bZIP transcription factor family protein Get druggable targets OG5_131442 All targets in OG5_131442
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131442 All targets in OG5_131442
Echinococcus granulosus jun protein Get druggable targets OG5_131442 All targets in OG5_131442
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor Get druggable targets OG5_131442 All targets in OG5_131442
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Schistosoma mansoni retinoblastoma-binding protein 4 (rbbp4) 0.0018 0.0006 0.0023
Loa Loa (eye worm) hypothetical protein 0.0099 0.3258 1
Brugia malayi hypothetical protein 0.008 0.2497 0.7409
Schistosoma mansoni hypothetical protein 0.0082 0.2608 1
Echinococcus multilocularis jun protein 0.0101 0.337 0.337
Echinococcus granulosus jun protein 0.0101 0.337 0.337
Echinococcus granulosus Ankyrin 0.0018 0.0006 0.0006
Echinococcus granulosus Basic leucine zipper bZIP transcription factor 0.0101 0.337 0.337
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription factor 0.0101 0.337 0.337
Echinococcus multilocularis nuclear factor of activated T cells 5 0.0267 1 1
Brugia malayi bZIP transcription factor family protein 0.0101 0.337 1
Onchocerca volvulus 0.008 0.2497 0.5
Schistosoma mansoni jun-related protein 0.0082 0.2608 1
Echinococcus multilocularis Ankyrin 0.0018 0.0006 0.0006

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.6 uM Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells ChEMBL. 11052805
IC50 (binding) = 0.6 uM Concentration required to inhibit activator protein-1(AP-1) mediated transcriptional activation in human Jurkat T-cells ChEMBL. 11052805
IC50 (binding) = 0.8 uM Concentration required to inhibit nuclear factor-kappa B) mediated transcriptional activation in human Jurkat T-cells. ChEMBL. 11052805
IC50 (binding) = 0.8 uM Concentration required to inhibit nuclear factor-kappa B) mediated transcriptional activation in human Jurkat T-cells. ChEMBL. 11052805
Permeability (ADMET) = 0.0000009 cm s-1 Compound was tested for permeability in Caco-2 cells by HPLC method ChEMBL. 11052805
Permeability (ADMET) = 0.0000009 cm s-1 Compound was tested for permeability in Caco-2 cells by HPLC method ChEMBL. 11052805

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.